Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratories ServierfiledCriticalLes Laboratories Servier
Priority to CU20070070ApriorityCriticalpatent/CU20070070A7/en
Publication of CU20070070A7publicationCriticalpatent/CU20070070A7/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
La presente invención se refiere a la utilización de la agolatina o N-[2-(7-metoxi-1-naftil)etil]acetamida para la obtención de medicamentos destinados al tratamiento del trastorno de ansiedad generalizada.The present invention relates to the use of agolatin or N- [2- (7-methoxy-1-naphthyl) ethyl] acetamide for obtaining medicaments for the treatment of generalized anxiety disorder.
CU20070070A2007-03-292007-03-29
PHARMACEUTICAL COMPOSITION OF AGOMELATIN
CU20070070A7
(en)